Prognosis
EU Regulator Approves Major Sites to Boost Vaccine Rollout
- EMA clears plants producing AstraZeneca, BioNTech vaccines
- Manufacturing sites are key to EU efforts to boost delivery
This article is for subscribers only.
The European Medicines Agency granted regulatory approval to two vaccination plants in the Netherlands and Germany in a boost for the European Union’s sluggish inoculation campaign.
The Dutch Halix facility, based in Leiden, is manufacturing the drug substance for the AstraZeneca Plc vaccine and had been awaiting approval to distribute the doses amid a significant shortfall of the shot’s deliveries for the EU.